These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8938308)

  • 1. Cortical hyperintensity on proton density-weighted images: An MR sign of cyclosporine-related encephalopathy.
    Jansen O; Krieger D; Krieger S; Sartor K
    AJNR Am J Neuroradiol; 1996 Feb; 17(2):337-44. PubMed ID: 8938308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of human leukocyte antigen disparity on cyclosporine neurotoxicity after allogeneic bone marrow transplantation.
    Zimmer WE; Hourihane JM; Wang HZ; Schriber JR
    AJNR Am J Neuroradiol; 1998 Apr; 19(4):601-8; discussion 609-10. PubMed ID: 9576643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogeneic bone marrow transplantation.
    Trullemans F; Grignard F; Van Camp B; Schots R
    Eur J Haematol; 2001 Aug; 67(2):94-9. PubMed ID: 11722596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions.
    Casey SO; Sampaio RC; Michel E; Truwit CL
    AJNR Am J Neuroradiol; 2000 Aug; 21(7):1199-206. PubMed ID: 10954269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical laminar necrosis caused by immunosuppressive therapy and chemotherapy.
    Bargalló N; Burrel M; Berenguer J; Cofan F; Buñesch L; Mercader JM
    AJNR Am J Neuroradiol; 2000 Mar; 21(3):479-84. PubMed ID: 10730638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine-related reversible posterior leukoencephalopathy: MRI.
    Jarosz JM; Howlett DC; Cox TC; Bingham JB
    Neuroradiology; 1997 Oct; 39(10):711-5. PubMed ID: 9351107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient MR signal changes in patients with generalized tonicoclonic seizure or status epilepticus: periictal diffusion-weighted imaging.
    Kim JA; Chung JI; Yoon PH; Kim DI; Chung TS; Kim EJ; Jeong EK
    AJNR Am J Neuroradiol; 2001; 22(6):1149-60. PubMed ID: 11415912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotoxicity in liver transplant recipients with cyclosporine immunosuppression.
    Wijdicks EF; Wiesner RH; Krom RA
    Neurology; 1995 Nov; 45(11):1962-4. PubMed ID: 7501141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of the cortical hyperintensity belt sign in fluid-attenuated inversion recovery images after bypass surgery for moyamoya disease.
    Hamano E; Kataoka H; Morita N; Maruyama D; Satow T; Iihara K; Takahashi JC
    J Neurosurg; 2017 Jan; 126(1):1-7. PubMed ID: 26894456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical blindness secondary to cyclosporine after orthotopic heart transplantation: a case report and review of the literature.
    Drachman BM; DeNofrio D; Acker MA; Galetta S; Loh E
    J Heart Lung Transplant; 1996 Nov; 15(11):1158-64. PubMed ID: 8956125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR of the brain in mitochondrial myopathy.
    Wray SH; Provenzale JM; Johns DR; Thulborn KR
    AJNR Am J Neuroradiol; 1995 May; 16(5):1167-73. PubMed ID: 7639148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blindness after liver transplant.
    Dawson DG; Trobe JD
    Surv Ophthalmol; 2002; 47(4):387-91. PubMed ID: 12161214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent cortical blindness after cyclosporine leukoencephalopathy.
    Casanova B; Prieto M; Deya E; Gisbert C; Mir J; Berenguer J; Vilchez JJ
    Liver Transpl Surg; 1997 Nov; 3(6):638-40. PubMed ID: 9404966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility-weighted imaging findings of cortical laminar necrosis in pediatric patients.
    Niwa T; Aida N; Shishikura A; Fujita K; Inoue T
    AJNR Am J Neuroradiol; 2008 Oct; 29(9):1795-8. PubMed ID: 18583404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe central nervous system toxicity after chronic treatment with cyclosporine.
    García-Escrig M; Martinez J; Fernandez-Ponsatí J; Diaz J; Soto O
    Clin Neuropharmacol; 1994 Jun; 17(3):298-302. PubMed ID: 9316676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine A neurotoxicity in a patient with idiopathic renal magnesium wasting.
    Al-Rasheed AK; Blaser SI; Minassian BA; Benson L; Weiss SK
    Pediatr Neurol; 2000 Oct; 23(4):353-6. PubMed ID: 11068171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible posterior leukoencephalopathy following organ transplantation. Description of two cases.
    Lanzino G; Cloft H; Hemstreet MK; West K; Alston S; Ishitani M
    Clin Neurol Neurosurg; 1997 Aug; 99(3):222-6. PubMed ID: 9350407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity.
    Bartynski WS; Zeigler Z; Spearman MP; Lin L; Shadduck RK; Lister J
    AJNR Am J Neuroradiol; 2001; 22(10):1901-14. PubMed ID: 11733324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine-induced white and grey matter central nervous system lesions in a pediatric renal transplant patient.
    Jeruss J; Braun SV; Reese JC; Guillot A
    Pediatr Transplant; 1998 Feb; 2(1):45-50. PubMed ID: 10084760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases.
    Schwartz RB; Bravo SM; Klufas RA; Hsu L; Barnes PD; Robson CD; Antin JH
    AJR Am J Roentgenol; 1995 Sep; 165(3):627-31. PubMed ID: 7645483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.